Loading...

BioPharma Credit PLC

BPCP.L•LSE
Financial Services
Asset Management
£64.51
£0.01(0.02%)

BioPharma Credit PLC (BPCP.L) Stock Overview

Explore BioPharma Credit PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 76.8/100

Key Financials

Market Cap735.2M
P/E Ratio10.07
EPS (TTM)$0.06
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Week$64.90
1 Month$64.79
3 Months$66.50
1 Year Target$61.66

BPCP.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioPharma Credit PLC (BPCP.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $61.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.07 and a market capitalization of 735.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

45.92RSI (14)
-0.21MACD
19.42ADX
Stats data is not available for BPCP.LStats details for BPCP.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for BPCP.LAnalyst Recommendations details for BPCP.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.

CEO

Pedro Gonzalez de Cosio

Headquarters

51 New North Road, Exeter

Founded

2021

Frequently Asked Questions

;